VFEND

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug VFEND contains one active pharmaceutical ingredient (API):

1	Voriconazole UNII JFU09I87TR - VORICONAZOLE
	Voriconazole is a triazole antifungal agent. The primary mode of action of voriconazole is the inhibition of fungal cytochrome P450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
	Read more about Voriconazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VFEND Powder for solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC03	Voriconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10168E, 10173K, 10198R, 9363T, 9364W, 9452L
BR	Câmara de Regulação do Mercado de Medicamentos	522717120068517, 522717120068617, 522717120068717
CA	Health Products and Food Branch	02256460, 02256479, 02256487, 02279991
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02704567, 02704610, 02704633, 11512430
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	412-MEE-0814, H4920513
EE	Ravimiamet	1107829, 1107830, 1107841, 1107852, 1107863, 1107874, 1107885, 1107896, 1107908, 1107931, 1107942, 1107953, 1107964, 1107975, 1107986, 1107997, 1108000, 1108011, 1108022, 1210150, 1629301
ES	Centro de información online de medicamentos de la AEMPS	02212005, 02212008, 02212015, 02212017, 02212025, 02212026
FI	Lääkealan turvallisuus- ja kehittämiskeskus	010192, 010326, 010886, 016382
FR	Base de données publique des médicaments	61120893, 63830251, 64665856, 66425767
GB	Medicines & Healthcare Products Regulatory Agency	43342, 43348, 48185, 79613
HK	Department of Health Drug Office	51220, 51221, 51222, 53423
IE	Health Products Regulatory Authority	88212, 88213, 88429
IL	מִשְׂרַד הַבְּרִיאוּת	4608, 4610, 4611, 4943, 8127
IT	Agenzia del Farmaco	035628054, 035628179, 035628419
JP	医薬品医療機器総合機構	6179001F1023, 6179001F2020, 6179001R1020, 6179401F1026
LT	Valstybinė vaistų kontrolės tarnyba	1010563, 1010564, 1010565, 1010566, 1010567, 1010568, 1010569, 1010570, 1010571, 1010572, 1010573, 1010574, 1010575, 1031160, 1031161, 1031162, 1031163, 1031164, 1031165, 1031166, 1031167, 1031168, 1031169, 1031170, 1031171, 1031172, 1071826, 1085907, 1085908, 1085909, 1085910, 1085911, 1085912, 1085913, 1085914, 1085915, 1085916, 1085917, 1085918, 1085919, 1085920, 1085921, 1085922, 1085923, 1085924
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	371M2002, 450M2002
NG	Registered Drug Product Database	A4-0540
Switch country to Nigeria in order to find specific presentations of VFEND
NL	Z-Index G-Standaard	14939886
NL	Z-Index G-Standaard, PRK	63592, 63614, 63622, 73288
NZ	Medicines and Medical Devices Safety Authority	10095, 10096, 10097, 11242
PL	Rejestru Produktów Leczniczych	100113340, 100113356, 100113362, 100126672
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64929001, W64930001, W64931001, W64931002
SG	Health Sciences Authority	12378P, 12379P, 12380P, 13033P
TN	Direction de la Pharmacie et du Médicament	8013051H, 8013052H, 8013053H, 8013054H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308091017, 8681308091116, 8681308261021, 8681308281050
US	FDA, National Drug Code	0049-3160, 0049-3170, 0049-3180, 0049-3190, 0049-4190
ZA	Health Products Regulatory Authority	36/20.1.7/0106, 36/20.1.7/0107, 36/20.1.7/0108